Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Niagen Bioscience, Inc. (NASDAQ: NAGE)
NAGE Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
40.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
113.20%
NAGE Stock Analysis
NAGE
PE Ratio:
16.4
NAGE
PEG Ratio:
0.5
NAGE
Forward EPS Growth (12 month):
32.50%
NAGE
PS Ratio:
2.1
NAGE
PSG Ratio:
0.1
NAGE
Forward Revenue Growth (12 month):
17.30%
NAGE Articles
No data was found